Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
Philippe Gabriel Steg,Michael Szarek,Deepak L Bhatt,Vera A Bittner,Marie-France Brégeault,Anthony J Dalby,Rafael Diaz,Jay M Edelberg,Shaun G Goodman,Corinne Hanotin,Robert A Harrington,J Wouter Jukema, Guillaume Lecorps,Kenneth W Mahaffey, Angèle Moryusef,Petr Ostadal,Alexander Parkhomenko,Robert Pordy,Matthew T Roe,Pierluigi Tricoci,Robert Vogel,Harvey D White,Andreas M Zeiher,Gregory G Schwartz Circulation（2019）
摘要
URL: https://www.clinicaltrials.gov . Unique identifier: NCT01663402.
更多查看译文
关键词
PCSK9 protein,acute coronary syndrome,alirocumab,cholesterol,mortality
AI 理解论文
溯源树
样例
